Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029647 · ClinicalTrials.gov registry record · NA
Mangos to Reduce Cardiometabolic Risk Markers
A NA study, sponsored by California State Polytechnic University, Pomona.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06029647 is a NA study that has completed, run by California State Polytechnic University, Pomona. The registered enrollment target is 40 participants.
The verdict
NCT06029647, a NA study, has completed, sponsored by California State Polytechnic University, Pomona.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research study will determine the effects of mango consumption on blood pressure, body weight, dietary nutrient/pattern changes, total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and HDL-cholesterol in individuals with moderately elevated blood pressure and/or LDL-cholesterol.
Interventions
- OTHER Mango
- OTHER vanilla wafers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2024-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06029647
The ClinicalTrials.gov registry entry for NCT06029647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California State Polytechnic University, Pomona, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mango is the first listed.
NCT06029647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06029647 about?
NCT06029647 is a clinical study titled "Mangos to Reduce Cardiometabolic Risk Markers". This research study will determine the effects of mango consumption on blood pressure, body weight, dietary nutrient/pattern changes, total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and HDL-cholesterol in individuals with moderately elevated blood pressure and/or LDL-cholesterol...
What is the current status of trial NCT06029647?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-18. Estimated completion is 2024-09-12.
What interventions are being tested in trial NCT06029647?
The interventions under investigation include: Mango (OTHER), vanilla wafers (OTHER).
Who is sponsoring clinical trial NCT06029647?
This trial is sponsored by California State Polytechnic University, Pomona, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.